Further, Kobayashi et al. proved that soluble inhibitors of UCH-L1 are effective in reducing lymph node metastasis of HNSCC; therefore, soluble inhibitors of UCH-L1 offer potential forms of treatment for invasive carcinomas, including EBV-positive malignancies [67]. The gene discussed is UCHL1; the disease is head and neck squamous cell carcinoma.